Author:
Booth Robert E.,Strathdee Steffanie A.
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology
Reference33 articles.
1. Fulminant hepatitis A in intravenous drug users with chronic liver disease;Akriviadis;Ann. Intern. Med.,1989
2. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young injection drug users in 5 U.S. cities;Bailey;Drug Alcohol Depend.,2007
3. Hepatitis A and hepatitis B vaccination of patients with chronic liver disease;Bell;Acta Gastroenterol. Belgica,2000
4. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users;Campbell;Drug and Alcohol Depend.,2007
5. Centers for Disease Control and Prevention, 1998. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Morb. Mortal. Wkly Rep. 47, 1–39.